TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

TROPICACYL

TROPICAMIDE Cholinergic Antagonists
Approved 2000-09-29
1
Indication
--
Phase 3 Trials
25
Years on Market

Details

Status
Prescription
First Approved
2000-09-29
Routes
OPHTHALMIC
Dosage Forms
SOLUTION/DROPS

Companies

Active Ingredient: TROPICAMIDE

TROPICACYL Approval History

Loading approval history...

What TROPICACYL Treats

2 indications

TROPICACYL is approved for 2 conditions since its original approval in 2000. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Mydriasis
  • Cycloplegia
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TROPICACYL FDA Label Details

Pro

Indications & Usage

For mydriasis and cycloplegia for diagnostic procedures.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.